China Rules: Drug Giant Faced a Reckoning as China Took Aim at Bribery

Photo of China Rules: Drug Giant Faced a Reckoning as China Took Aim at Bribery
Facebook
VKontakte
share_fav

China sought to make an example of the GlaxoSmithKline case, which involved bribery of doctors and investigators and ended with guilty pleas and record penalties.

view The New York Times: Business
#frauds and swindling
#bribery and kickbacks
#whistle-blowers
#glaxosmithkline plc